管壁增厚型胆囊癌患者MRI影像学特征分析*

doi:10.3969/j.issn.1672-5069.2021.05.038

摘要/Abstract

摘要： 目的探讨慢性胆囊炎与壁增厚型胆囊癌患者磁共振成像(MRI)影像学特征异同,以帮助对壁增厚型胆囊癌患者的鉴别诊断。方法 2019年1月～2020年12月我院收治的胆囊疾病患者60例,使用超导MRI成像仪进行影像学检查,比较慢性胆囊炎和胆囊癌的MRI影像学特征差异。对慢性胆囊炎患者,行胆囊切除术,对胆囊癌患者,行肿瘤切除术。结果 21例壁增厚型胆囊癌组胆囊宽度和胆囊壁厚度分别为(3.5±0.4)cm和(1.5±0.2)cm,显著大于39例慢性胆囊炎组【分别为(2.7±0.4)cm和(1.1±0.1)cm,P<0.05】,与邻近脏器界面模糊、胆道梗阻、胆囊壁僵硬、胆囊形态不规则和胆囊黏膜线不完整检出率分别为61.9%、76.2%、71.4%、85.7%和95.2%,均显著大于慢性胆囊炎组的0.0%、10.3%、2.6%、25.6%和0.0%,差异有统计学意义(P＜0.05)。结论应用MRI检查能很好地分辨慢性胆囊炎与壁增厚型胆囊癌,后者的一些特征性表现有助于临床医生诊断。

关键词: 胆囊癌, 慢性胆囊炎, 磁共振成像, 特征, 诊断

Abstract: Objective The aim of this study was to summarize the magnetic resonance imaging (MRI) characteristics of patients with wall-thickening gallbladder carcinoma. Methods A total of 60 patients with gallbladder diseases were admitted to our hospital between January 2019 and December 2020, and all patients underwent MR scan and surgical cholecystectomy or radical cholecystectomy. Results The gallbladder width and gallbladder wall thickness in 21 patients with wall-thickening gallbladder carcinoma were (3.5±0.4)cm and (1.5±0.2)cm, significantly larger than in 39 patients with chronic cholecystitis, and the incidences of blurred interface with adjacent tissues, biliary obstruction, gallbladder wall stiffness, irregular gallbladder morphology and incomplete gallbladder mucosal line in patients with thick-thickening gallbladder carcinoma were 61.9%, 76.2%, 71.4%, 85.7% and 95.2%, all significantly higher than 0.0%, 10.3%, 2.6%, 25.6% and 0.0%, respectively, in patients with chronic cholecystitis (P＜0.05). Conclusion MRI is high valuable in diagnosis and differentiation of patients with wall-thickening gallbladder carcinoma, which has some characteristic features for clinicians to make medical plan early for them.

Key words: Gallbladder carcinoma, Chronic cholecystitis, Magnetic resonance imaging, Feature, Diagnosis

徐燕, 李啸天, 刘慧, 陈渝晖. 管壁增厚型胆囊癌患者MRI影像学特征分析^*[J]. 实用肝脏病杂志, 2021, 24(5): 757-760.

Xu Yan, Li Xiaotian, Liu Hui, et al. MRI features of patients with wall-thickening gallbladder carcinoma[J]. Journal of Practical Hepatology, 2021, 24(5): 757-760.

参考文献

[1]Vahedi A,Azimpouran M,Ghavidel A ,et al. Synchronousgallbladder squamous cell carcinoma and adenocarcinoma both as primary tumors in one patient. IntJ Surg Case Rep,2018,45(12):1-3.
[2]陈晨,张东,王林,等. 原发性胆囊癌根治术的临床疗效和预后分析. 中华消化外科杂志, 2019,18(2):128-134.
[3]Yasufumi S ,Hiroshi O ,Makoto Y ,et al. Gallbladder metastasis of renal clear cell carcinoma 15 years after primary cancer excision: a case report.Int J Surg Case Rep, 2018,45(29):1-3.
[4]奇丽霞,林澜,白旭,等. 常规MRI结合扩散加权成像评估胆囊癌T分期并判断其组织学分级. 中华肝胆外科杂志,2019,25(10):741-745.
[5]黄海,何承祥,肖诗铭,等. 急性胆囊炎与胆囊癌影像学的诊断鉴别分析. 中国CT和MRI杂志,2014,26(8):49-51.
[6]曾红英,李金莲. 胆囊癌的超声造影表现. 实用肝脏病杂志,2018,21(4):645-646.
[7]中华消化杂志编辑委员会,中华医学会消化病学分会肝胆疾病协作组. 中国慢性胆囊炎、胆囊结石内科诊疗共识意见(2018年). 中华消化杂志,2019,39(2):73-79.
[8]中华医学会外科学分会胆道外科学组,中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版). 中华外科杂志,2020,58(4):243-251.
[9]朱斌,蔡权宇,俞文隆,等. 胆囊癌合并胆管侵犯手术治疗60例临床分析. 中华外科杂志,2020,58(10):801-805.
[10] 周迪,全志伟. 以肿瘤学理念审视胆囊癌的综合治疗. 中华外科杂志,2020,58(1):801-805.
[11] 吕文才,邹运,温爽,等. 中国胆囊癌发病率和流行趋势分析. 中华消化外科杂志,2019,18(2):186-189.
[12] Gomes A F ,Fernandes S ,Martins J,et al. Carcinoma of the gallbladder presenting as haemorrhagic cholecystitis. BMJ Case Rep,2020,13(3):232-233.
[13] Suzuki K , Abe K , Ohbu M . A resected gallbladder carcinoma coexisting with adenomyomatosis involving varied degrees of intraepithelial dysplasia: a case report and literature review. Surg Laparo Endo Per, 2018, 29(4):290-296.
[14] 余红胜,沈又利,吉六舟,等. 慢性胆囊炎与壁厚型胆囊癌的CT鉴别诊断. 中国医学计算机成像杂志,2012,30(4):322-325.
[15] Agrawal S , Alam N , Rastogi N , et al. Chemotherapy (CT) orchemoradiation (CTRT) in postoperative (simple cholecystectomy) carcinoma gall bladder (GBC) with residual disease, unsuitable for revision surgery. J Clin Oncol, 2019, 37(15):15594-15594.
[16] Takahashi, T. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res, 2015, 10(18):6126-6133.
[17] Marcus S S , Kaur J , Yadav H P . Gall bladder carcinoma (gbc): rising incidences in the Malwa belt region of Northern India a hospital based cancer registry. Int J Legal Med, 2018, 6(3):108-111.
[18] Yanagisawa N , Yamashita K , Kuba T , et al. Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis. Anticancer Res, 2010, 30(11):4443-4449.
[19] 张东,耿智敏,陈晨,等.胆囊癌的临床分型和预后关系初步分析:多中心回顾性临床研究. 中华外科杂志,2019,57(4):258-264.
[20] Rhee H , Cho E S , Nahm J H , et al. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications. J Hepatol, 2021, 74( 1):109-121.

管壁增厚型胆囊癌患者MRI影像学特征分析^*

MRI features of patients with wall-thickening gallbladder carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	汤磊, 邹桂舟. 外科疾病导致的胆源性肝损伤诊治现状[J]. 实用肝脏病杂志, 2021, 24(6): 769-771.
[2]	邢莉, 杜倩影, 姜艳丽, 韩冬. 分段注射对比剂CT增强扫描提高乙型肝炎肝硬化患者肝静脉显影效果研究^*[J]. 实用肝脏病杂志, 2021, 24(6): 871-874.
[3]	吴慧娟, 何年安, 谢蠡, 叶显俊, 章生龙, 刘力. 超声造影联合血清CA19-9鉴别诊断胆管细胞癌与肝细胞癌应用研究[J]. 实用肝脏病杂志, 2021, 24(6): 903-906.
[4]	周正, 刘玮. 肝血管瘤、肝细胞癌和肝血管平滑肌脂肪瘤超声造影特点观察^*[J]. 实用肝脏病杂志, 2021, 24(6): 911-914.
[5]	武琼, 孙洋, 刘娜, 张锦. 失代偿期肝硬化并发败血症患者外周血白细胞VCS参数变化及其临床价值分析[J]. 实用肝脏病杂志, 2021, 24(5): 633-636.
[6]	王利公, 赵珊, 白凯, 张宁, 张楠. 慢性乙型肝炎患者血清α1酸性糖蛋白、α1-抗胰蛋白酶和触珠蛋白变化及其临床意义探讨[J]. 实用肝脏病杂志, 2021, 24(5): 673-676.
[7]	杨永汉, 路萍, 孟庆宁, 张枫婕. 增强MRI T1 mapping定量评估慢性乙型肝炎患者肝纤维化程度效能分析[J]. 实用肝脏病杂志, 2021, 24(5): 685-688.
[8]	葛海燕, 匡霞, 周瑞君. 非酒精性脂肪性肝病合并2型糖尿病患者外周血miR-17、miR-20a和miR-20b变化及其临床意义^*[J]. 实用肝脏病杂志, 2021, 24(5): 697-700.
[9]	黄霜湘, 姚朝光, 蓝婧, 欧琴, 覃冬林, 陈丽芬, 黄洁婕. 慢加急性乙型肝炎肝衰竭患者血清自噬相关蛋白水平及其临床意义探讨^*[J]. 实用肝脏病杂志, 2021, 24(5): 721-724.
[10]	梁旭, 刘圆圆, 杨学刚, 任静. 基于2018年版肝脏影像报告数据系统对比分析CT和MRI诊断肝细胞癌的效能^*[J]. 实用肝脏病杂志, 2021, 24(5): 725-728.
[11]	张武花, 栗海龙, 秦启斌, 史纲. CT自动管电流调节联合自适应迭代算法技术诊断肝血管瘤价值分析^*[J]. 实用肝脏病杂志, 2021, 24(5): 749-752.
[12]	李变利, 徐丽红. 药物性肝损伤、药物诱导性自身免疫性肝炎和自身免疫性肝炎鉴别诊断研究进展^*[J]. 实用肝脏病杂志, 2021, 24(4): 460-463.
[13]	孙海荣, 冯伟广, 周冰清, 刘慧敏, 蒋蓓莉. 不同血清ALT水平的乙型肝炎病毒感染者肝纤维化指标变化[J]. 实用肝脏病杂志, 2021, 24(4): 488-491.
[14]	安红杰, 徐金凤, 耿华, 葛志胜, 何文艳, 赵崇山, 高美丽, 陈俊, 周东方. FibroScan行肝脏硬度检测和APRI评估慢性丙型肝炎患者肝纤维化程度价值比较^*[J]. 实用肝脏病杂志, 2021, 24(4): 492-495.
[15]	王嘉妮, 刘湧, 周忻, 任传路, 缪惠锴. 慢性丙型肝炎患者血清microRNA-1273g-3p水平预测肝硬化价值分析^*[J]. 实用肝脏病杂志, 2021, 24(4): 496-499.